• 4943 Citations
  • 37 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sae-Won Han is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 61 Similar Profiles
Drug Therapy Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Survival Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients

Lee, D. W., Ryu, H. S., Jin, M. S., Lee, K. H., Suh, K. J., Youk, J., Kim, J. Y., Min, A., Lee, H. B., Moon, H. G., Kim, T. Y., Han, S-W., Oh, D-Y., Han, W., Park, I., Noh, D. & Im, S-A., 30 Jul 2019, In : British Journal of Cancer. 121, 3, p. 230-236 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Breast Neoplasms
Recurrence
Proteins
Biomarkers
Tumor-Infiltrating Lymphocytes
1 Citation (Scopus)

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

Kim, J. Y., Lee, D. W., Lee, K-H., Min, A., Ryu, H. S., Lee, H-B., Moon, H. G., Kim, T-Y., Han, S-W., Oh, D-Y., Han, W., Park, I., Noh, D., Im, S-A. & Kim, S., 30 Jul 2019, In : Breast Cancer Research and Treatment. 176, 2, p. 453-460 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Body Mass Index
Hormones
Breast Neoplasms
Thinness
Neoplasms

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

Suh, K. J., Ryu, H. S., Lee, K-H., Kim, H., Min, A., Kim, T-Y., Yang, Y., Lee, H-B., Moon, H. G., Han, S-W., Oh, D-Y., Han, W., Park, I., Noh, D. & Im, S-A., 15 May 2019, In : Breast Cancer Research and Treatment. 175, 1, p. 117-127 11 p.

Research output: Contribution to journalArticleResearchpeer-review

DNA Damage
Breast Neoplasms
Proteins
Triple Negative Breast Neoplasms
Disease-Free Survival

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy

Lee, D. W., Han, S-W., Cha, Y., Bae, J. M., Kim, H. P., Lyu, J., Han, H., Kim, H., Jang, H., Bang, D., Won, J. K., Jeong, S-Y., Park, K. J., Kang, G. H. & Kim, T., 6 May 2019, In : BMC Cancer. 19, 1, 421.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
oxaliplatin
Colorectal Neoplasms
Recurrence
Drug Therapy
Mutation

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Oh, H. J., Bae, J. M., Wen, X., Jung, S., Kim, Y., Kim, K. J., Cho, N. Y., Kim, J. H., Han, S-W., Kim, T. & Kang, G. H., 16 Apr 2019, In : British Journal of Cancer. 120, 8, p. 797-805 9 p.

Research output: Contribution to journalArticleResearchpeer-review

oxaliplatin
Adjuvant Chemotherapy
Colorectal Neoplasms
Survival
Confidence Intervals